Table 4.
The association of hypothyroidism, DM and hypertension statuses with poor SRH at follow-up. The HUNT study 1995–97 (baseline) and 2006–08 (follow-up)
| Women | OR (95% CI) | |||
|---|---|---|---|---|
| N | Model 1 | Model 2 | Model 3 | |
| Hypothyroidism | ||||
| A. No disease, baseline and follow-up | 6731 | 1.00 | 1.00 | 1.00 |
| B. Unknown, baseline and/or follow-up | 103 | 0.51 (0.33–0.79) | 0.59 (0.36–0.96) | 0.64 (0.38–1.06) |
| C. Unknown baseline, known follow-up | 197 | 1.44 (1.11–1.87) | 1.62 (1.20–2.19) | 1.83 (1.33–2.52) |
| D. No disease baseline, known follow-up | 338 | 1.81 (1.48–2.22) | 1.72 (1.36–2.17) | 1.56 (1.22–2.00) |
| E. Known baseline | 545 | 1.77 (1.51–2.07) | 1.66 (1.37–2.00) | 1.39 (1.13–1.70) |
| DM | ||||
| A. No disease, baseline and follow-up | 3750 | 1.00 | 1.00 | 1.00 |
| B. Unknown, baseline and/or follow-up | 1378 | 1.08 (0.96–1.22) | 0.99 (0.85–1.14) | 1.00 (0.86–1.17) |
| C. Unknown baseline, known follow-up | 86 | 1.74 (1.19–2.54) | 1.31 (0.83–2.09) | 1.46 (0.89–2.38) |
| D. No disease baseline, known follow-up | 95 | 1.67 (1.14–2.43) | 1.12 (0.72–1.76) | 1.11 (0.68–1.79) |
| E. Known baseline | 68 | 2.23 (1.45–3.44) | 1.53 (0.89–2.61) | 1.21 (0.67–2.16) |
| Hypertension | ||||
| A. No disease, baseline and follow-up | 7799 | 1.00 | 1.00 | 1.00 |
| B. Unknown, baseline and/or follow-up | 2173 | 1.01 (0.91–1.11) | 0.86 (0.76–0.97) | 0.89 (0.79–1.01) |
| C. Unknown baseline, known follow-up | 1259 | 1.44 (1.28–1.62) | 1.19 (1.04–1.37) | 1.21 (1.04–1.41) |
| D. No disease baseline, known follow-up | 802 | 2.02 (1.76–2.31) | 1.60 (1.36–1.88) | 1.52 (1.28–1.81) |
| E. Known baseline | 1841 | 1.76 (1.59–1.94) | 1.44 (1.28–1.63) | 1.33 (1.17–1.52) |
| Men | ||||
|---|---|---|---|---|
| Hypothyroidism | ||||
| A. No disease, baseline and follow-up | 3383 | 1.00 | 1.00 | 1.00 |
| B. Unknown, baseline and/or follow-up | 41 | 0.72 (0.37–1.38) | 0.61 (0.28–1.34) | 0.63 (0.12–3.34) |
| C. Unknown baseline, known follow-up | 35 | 1.23 (0.66–2.30) | 1.36 (0.65–2.84) | 1.10 (0.51–2.39) |
| D. No disease baseline, known follow-up | 51 | 1.91 (1.19–3.07) | 2.22 (1.23–4.00) | 1.26 (0.81–1.95) |
| E. Known baseline | 70 | 1.04 (0.65–1.68) | 0.78 (0.45–1.35) | 0.41 (0.19–0.90) |
| DM | ||||
| A. No disease, baseline and follow-up | 2753 | 1.00 | 1.00 | 1.00 |
| B. Unknown, baseline and/or follow-up | 1653 | 1.06 (0.93–1.21) | 1.07 (0.92–1.25) | 1.07 (0.91–1.25) |
| C. Unknown baseline, known follow-up | 94 | 1.89 (1.30–2.74) | 1.49 (0.94–2.34) | 1.29 (0.80–2.10) |
| D. No disease baseline, known follow-up | 82 | 2.04 (1.37–3.03) | 1.63 (1.01–2.64) | 1.55 (0.93–2.57) |
| E. Known baseline | 67 | 2.93 (1.84–4.66) | 2.99 (1.76–5.06) | 2.52 (1.46–4.34) |
| Hypertension | ||||
| A. No disease, baseline and follow-up | 5271 | 1.00 | 1.00 | 1.00 |
| B. Unknown, baseline and/or follow-up | 2327 | 0.92 (0.82–1.03) | 0.93 (0.81–1.06) | 0.95 (0.83–1.09) |
| C. Unknown baseline, known follow-up | 1199 | 1.58 (1.38–1.79) | 1.56 (1.34–1.82) | 1.60 (1.36–1.87) |
| D. No disease baseline, known follow-up | 526 | 2.22 (1.87–2.64) | 2.01 (1.64–2.46) | 2.04 (1.65–2.52) |
| E. Known baseline | 1934 | 1.90 (1.70–2.12) | 1.72 (1.51–1.96) | 1.54 (1.34–1.77) |
OR for poor SRH with 95% CIs. Model 1: adjusted for age only. Model 2: model 1 + smoking status, BMI, education level, self-esteem and long-term illness or injury. Model 3: model 2 + baseline SRH. N represents numbers included in the fully adjusted analyses, cases with missing data excluded. CI, confidence interval.